Anavex Life Sciences Corp. reported that Felix Lauscher, the Chief Operating Officer, left the company on May 11, 2026, as part of a reorganization after Dr. Terrie Kellmeyer's appointment as Interim CEO. During his tenure, Lauscher had an annual salary of $264,000 and was granted stock options, most of which were forfeited upon his departure.